Skip to main content
. 2019 Nov 27;5:JGO.19.00025. doi: 10.1200/JGO.19.00025

FIG 1.

FIG 1

Disposition of (A) all patients and those with (B) multiple myeloma (MM), (C) chronic lymphocytic leukemia (CLL), and (D) non-Hodgkin lymphoma (NHL).